{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:03:28Z","timestamp":1791475408785,"version":"4.3.4"},"reference-count":84,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T00:00:00Z","timestamp":1681344000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"UKRI Medical Research Council","doi-asserted-by":"publisher","award":["MC PC 13030"],"award-info":[{"award-number":["MC PC 13030"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"UKRI Medical Research Council","doi-asserted-by":"publisher","award":["MR\/W019132\/1"],"award-info":[{"award-number":["MR\/W019132\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"UKRI Medical Research Council","doi-asserted-by":"publisher","award":["MC UP A90 1006"],"award-info":[{"award-number":["MC UP A90 1006"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Governo Italiano Ministero dell&apos;Istruzione dell&apos;Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018956","name":"NIHR Cambridge Biomedical Research Centre","doi-asserted-by":"publisher","award":["IS-BRC-1215-20014"],"award-info":[{"award-number":["IS-BRC-1215-20014"]}],"id":[{"id":"10.13039\/501100018956","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022315","name":"Mason Medical Research Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022315","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005362","name":"University of Bari Aldo Moro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005362","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012111","name":"Foundation for Liver Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012111","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004282","name":"Evelyn Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004282","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019573","name":"BHF","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019573","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["27521"],"award-info":[{"award-number":["27521"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["IG2022"],"award-info":[{"award-number":["IG2022"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["FS\/18\/53\/33863"],"award-info":[{"award-number":["FS\/18\/53\/33863"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000735","name":"University of Cambridge","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000691","name":"Academy of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Metabolism"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.molmet.2023.101728","type":"journal-article","created":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T04:26:28Z","timestamp":1681878388000},"page":"101728","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"special_numbering":"C","title":["Non-alcoholic fatty liver disease is characterised by a reduced polyunsaturated fatty acid transport via free fatty acids and high-density lipoproteins (HDL)"],"prefix":"10.1016","volume":"73","author":[{"given":"Gabriele","family":"Mocciaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Allison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vian","family":"Azzu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Huang-Doran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Vicente","family":"Herrera-Marcos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Murgia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davies","family":"Susan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattia","family":"Frontini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Vidal-Puig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Koulman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian L.","family":"Griffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1973-224X","authenticated-orcid":false,"given":"Michele","family":"Vacca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.molmet.2023.101728_bib1","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1053\/j.gastro.2019.12.054","article-title":"Adipose tissue-liver cross talk in the control of whole-body metabolism: implications in nonalcoholic fatty liver disease","volume":"158","author":"Azzu","year":"2020","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.molmet.2023.101728_bib2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.molmet.2023.101728_bib3","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.molmet.2023.101728_bib4","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1136\/gutjnl-2020-320622","article-title":"NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications","volume":"69","author":"Targher","year":"2020","journal-title":"Gut"},{"issue":"11","key":"10.1016\/j.molmet.2023.101728_bib5","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S2468-1253(21)00308-3","article-title":"Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis","volume":"6","author":"Mantovani","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"12","key":"10.1016\/j.molmet.2023.101728_bib6","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/s41575-021-00502-9","article-title":"Metabolomics and lipidomics in NAFLD: biomarkers and non-invasive diagnostic tests","volume":"18","author":"Masoodi","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.molmet.2023.101728_bib7","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13695","article-title":"Adipose tissue insulin resistance and lipidome alterations as the characterizing factors of non-alcoholic steatohepatitis","volume":"52","author":"Guerra","year":"2022","journal-title":"Eur J Clin Invest"},{"issue":"5","key":"10.1016\/j.molmet.2023.101728_bib8","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/s41574-021-00471-8","article-title":"Lipid and glucose metabolism in white adipocytes: pathways, dysfunction and therapeutics","volume":"17","author":"Morigny","year":"2021","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.molmet.2023.101728_bib9","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/164_2021_573","article-title":"Obesity-related insulin resistance: the central role of adipose tissue dysfunction","volume":"274","author":"Mocciaro","year":"2022","journal-title":"Handb Exp Pharmacol"},{"issue":"7","key":"10.1016\/j.molmet.2023.101728_bib10","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/hep4.1188","article-title":"Metabolomic-based noninvasive serum test to diagnose nonalcoholic steatohepatitis: results from discovery and validation cohorts","volume":"2","author":"Mayo","year":"2018","journal-title":"Hepatol Commun"},{"issue":"1","key":"10.1016\/j.molmet.2023.101728_bib11","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s13059-018-1439-8","article-title":"Hepatic steatosis risk is partly driven by increased de novo lipogenesis following carbohydrate consumption","volume":"19","author":"Sanders","year":"2018","journal-title":"Genome Biol"},{"issue":"1","key":"10.1016\/j.molmet.2023.101728_bib12","article-title":"Serum monounsaturated triacylglycerol predicts steatohepatitis in patients with non-alcoholic fatty liver disease and chronic hepatitis B","volume":"7","author":"Yang","year":"2017","journal-title":"Sci Rep"},{"issue":"10","key":"10.1016\/j.molmet.2023.101728_bib13","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.cgh.2016.05.046","article-title":"Noninvasive detection of nonalcoholic steatohepatitis using clinical markers and circulating levels of lipids and metabolites","volume":"14","author":"Zhou","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.molmet.2023.101728_bib14","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI23621","article-title":"Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease","volume":"115","author":"Donnelly","year":"2005","journal-title":"J\u00a0Clin Invest"},{"issue":"5","key":"10.1016\/j.molmet.2023.101728_bib15","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/j.clnu.2019.06.013","article-title":"Metabolomics reveals plausible interactive effects between dairy product consumption and metabolic syndrome in humans","volume":"39","author":"Capel","year":"2020","journal-title":"Clin Nutr"},{"issue":"5","key":"10.1016\/j.molmet.2023.101728_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/nu10050649","article-title":"Circulating phospholipid patterns in NAFLD patients associated with a combination of metabolic risk factors","volume":"10","author":"Tiwari-Heckler","year":"2018","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.molmet.2023.101728_bib17","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.jhep.2021.04.013","article-title":"Hepatic lipidomic remodeling in severe obesity manifests with steatosis and does not evolve with non-alcoholic steatohepatitis","volume":"75","author":"Ooi","year":"2021","journal-title":"J\u00a0Hepatol"},{"issue":"23","key":"10.1016\/j.molmet.2023.101728_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21238985","article-title":"Obesity-related changes in high-density lipoprotein metabolism and function","volume":"21","author":"Stadler","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.molmet.2023.101728_bib19","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13148-022-01257-z","article-title":"Transcriptional, epigenetic and metabolic signatures in cardiometabolic syndrome defined by extreme phenotypes","volume":"14","author":"Seyres","year":"2022","journal-title":"Clin Epigenetics"},{"issue":"12","key":"10.1016\/j.molmet.2023.101728_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23126786","article-title":"Lipidomic approaches to study HDL metabolism in patients with central obesity diagnosed with metabolic syndrome","volume":"23","author":"Mocciaro","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.molmet.2023.101728_bib21","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.molmet.2023.101728_bib22","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1002\/hep.25889","article-title":"Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients","volume":"56","author":"Bedossa","year":"2012","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.molmet.2023.101728_bib23","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1053\/j.gastro.2009.06.005","article-title":"Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors","volume":"137","author":"Kotronen","year":"2009","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.molmet.2023.101728_bib24","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/nrendo.2016.169","article-title":"Sphingolipids and phospholipids in insulin resistance and related metabolic disorders","volume":"13","author":"Meikle","year":"2017","journal-title":"Nat Rev Endocrinol"},{"issue":"12","key":"10.1016\/j.molmet.2023.101728_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3001049","article-title":"Correction: high-coverage plasma lipidomics reveals novel sex-specific lipidomic fingerprints of age and BMI: evidence from two large population cohort studies","volume":"18","author":"Beyene","year":"2020","journal-title":"PLoS Biol"},{"key":"10.1016\/j.molmet.2023.101728_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101210","article-title":"Suppression of insulin-induced gene 1 (INSIG1) function promotes hepatic lipid remodelling and restrains NASH progression","volume":"48","author":"Azzu","year":"2021","journal-title":"Mol Metab"},{"issue":"3","key":"10.1016\/j.molmet.2023.101728_bib27","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1172\/JCI134165","article-title":"Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease","volume":"130","author":"Smith","year":"2020","journal-title":"J\u00a0Clin Invest"},{"issue":"2","key":"10.1016\/j.molmet.2023.101728_bib28","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ab.2012.01.027","article-title":"Analysis of sphingolipids in extracted human plasma using liquid chromatography electrospray ionization tandem mass spectrometry","volume":"423","author":"Bui","year":"2012","journal-title":"Anal Biochem"},{"issue":"10","key":"10.1016\/j.molmet.2023.101728_bib29","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.1194\/jlr.D008532","article-title":"Blood sphingolipidomics in healthy humans: impact of sample collection methodology","volume":"51","author":"Hammad","year":"2010","journal-title":"J\u00a0Lipid Res"},{"issue":"6","key":"10.1016\/j.molmet.2023.101728_bib30","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1111\/acel.12369","article-title":"Demographic and clinical variables affecting mid- to late-life trajectories of plasma ceramide and dihydroceramide species","volume":"14","author":"Mielke","year":"2015","journal-title":"Aging Cell"},{"key":"10.1016\/j.molmet.2023.101728_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2021.100104","article-title":"Nonalcoholic fatty liver disease stratification by liver lipidomics","volume":"62","author":"Vvedenskaya","year":"2021","journal-title":"J\u00a0Lipid Res"},{"issue":"8","key":"10.1016\/j.molmet.2023.101728_bib32","doi-asserted-by":"crossref","DOI":"10.1172\/JCI135963","article-title":"Lysophospholipid acylation modulates plasma membrane lipid organization and insulin sensitivity in skeletal muscle","volume":"131","author":"Ferrara","year":"2021","journal-title":"J\u00a0Clin Invest"},{"issue":"6","key":"10.1016\/j.molmet.2023.101728_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1000623","article-title":"Association of lipidome remodeling in the adipocyte membrane with acquired obesity in humans","volume":"9","author":"Pietilainen","year":"2011","journal-title":"PLoS Biol"},{"issue":"4","key":"10.1016\/j.molmet.2023.101728_bib34","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJM199301283280404","article-title":"The relation between insulin sensitivity and the fatty-acid composition of skeletal-muscle phospholipids","volume":"328","author":"Borkman","year":"1993","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.molmet.2023.101728_bib35","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1161\/CIRCULATIONAHA.106.621433","article-title":"Both hepatic and extrahepatic ABCA1 have discrete and essential functions in the maintenance of plasma high-density lipoprotein cholesterol levels in\u00a0vivo","volume":"114","author":"Singaraja","year":"2006","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.molmet.2023.101728_bib36","doi-asserted-by":"crossref","first-page":"797","DOI":"10.2337\/db10-0705","article-title":"Differential lipid partitioning between adipocytes and tissue macrophages modulates macrophage lipotoxicity and M2\/M1 polarization in obese mice","volume":"60","author":"Prieur","year":"2011","journal-title":"Diabetes"},{"issue":"11","key":"10.1016\/j.molmet.2023.101728_bib37","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1194\/jlr.M700139-JLR200","article-title":"Sphingomyelin-dependence of cholesterol efflux mediated by ABCG1","volume":"48","author":"Sano","year":"2007","journal-title":"J\u00a0Lipid Res"},{"issue":"12","key":"10.1016\/j.molmet.2023.101728_bib38","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1161\/ATVBAHA.113.301468","article-title":"Small, dense high-density lipoprotein-3 particles are enriched in negatively charged phospholipids: relevance to cellular cholesterol efflux, antioxidative, antithrombotic, anti-inflammatory, and antiapoptotic functionalities","volume":"33","author":"Camont","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"28","key":"10.1016\/j.molmet.2023.101728_bib39","doi-asserted-by":"crossref","first-page":"23418","DOI":"10.1074\/jbc.M112.381723","article-title":"The membrane lipid phosphatidylcholine is an unexpected source of triacylglycerol in the liver","volume":"287","author":"van der Veen","year":"2012","journal-title":"J\u00a0Biol Chem"},{"issue":"2","key":"10.1016\/j.molmet.2023.101728_bib40","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1053\/j.gastro.2018.06.031","article-title":"Bioactive lipid species and metabolic pathways in progression and resolution of nonalcoholic steatohepatitis","volume":"155","author":"Musso","year":"2018","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.molmet.2023.101728_bib41","doi-asserted-by":"crossref","first-page":"436","DOI":"10.4254\/wjh.v12.i8.436","article-title":"Lipidomics in non-alcoholic fatty liver disease","volume":"12","author":"Kartsoli","year":"2020","journal-title":"World J Hepatol"},{"issue":"4","key":"10.1016\/j.molmet.2023.101728_bib42","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.jhep.2014.11.002","article-title":"Circulating phospholipid profiling identifies portal contribution to NASH signature in obesity","volume":"62","author":"Anjani","year":"2015","journal-title":"J\u00a0Hepatol"},{"issue":"10","key":"10.1016\/j.molmet.2023.101728_bib43","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1007\/s00125-013-2981-2","article-title":"Prediction of non-alcoholic fatty-liver disease and liver fat content by serum molecular lipids","volume":"56","author":"Oresic","year":"2013","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.molmet.2023.101728_bib44","doi-asserted-by":"crossref","DOI":"10.3390\/metabo10040163","article-title":"A\u00a0review of lipidomics of cardiovascular disease highlights the importance of isolating lipoproteins","volume":"10","author":"Ding","year":"2020","journal-title":"Metabolites"},{"issue":"11","key":"10.1016\/j.molmet.2023.101728_bib45","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1194\/jlr.R036095","article-title":"Unraveling the complexities of the HDL lipidome","volume":"54","author":"Kontush","year":"2013","journal-title":"J\u00a0Lipid Res"},{"issue":"2","key":"10.1016\/j.molmet.2023.101728_bib46","doi-asserted-by":"crossref","first-page":"401","DOI":"10.2337\/db12-0686","article-title":"Ceramides contained in LDL are elevated in type 2 diabetes and promote inflammation and skeletal muscle insulin resistance","volume":"62","author":"Boon","year":"2013","journal-title":"Diabetes"},{"issue":"9","key":"10.1016\/j.molmet.2023.101728_bib47","article-title":"Dihydroceramides in triglyceride-enriched VLDL are associated with nonalcoholic fatty liver disease severity in type 2 diabetes","volume":"1","author":"Carlier","year":"2020","journal-title":"Cell Rep Med"},{"issue":"4","key":"10.1016\/j.molmet.2023.101728_bib48","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1007\/s00125-009-1282-2","article-title":"Serum saturated fatty acids containing triacylglycerols are better markers of insulin resistance than total serum triacylglycerol concentrations","volume":"52","author":"Kotronen","year":"2009","journal-title":"Diabetologia"},{"issue":"5","key":"10.1016\/j.molmet.2023.101728_bib49","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/0026-0495(87)90051-5","article-title":"Acute elevation of free fatty acid levels leads to hepatic insulin resistance in obese subjects","volume":"36","author":"Bevilacqua","year":"1987","journal-title":"Metabolism"},{"issue":"5","key":"10.1016\/j.molmet.2023.101728_bib50","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1002\/hep.25539","article-title":"Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease","volume":"55","author":"Lomonaco","year":"2012","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.molmet.2023.101728_bib51","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1054\/clnu.2001.0529","article-title":"Plasma total and free fatty acids composition in human non-alcoholic steatohepatitis","volume":"21","author":"de Almeida","year":"2002","journal-title":"Clin Nutr"},{"issue":"1","key":"10.1016\/j.molmet.2023.101728_bib52","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s12944-017-0551-1","article-title":"Free fatty acids profile among lean, overweight and obese non-alcoholic fatty liver disease patients: a case - control study","volume":"16","author":"Feng","year":"2017","journal-title":"Lipids Health Dis"},{"issue":"4","key":"10.1016\/j.molmet.2023.101728_bib53","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3390\/ijms17040479","article-title":"Different serum free fatty acid profiles in NAFLD subjects and healthy controls after oral fat load","volume":"17","author":"Gambino","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.molmet.2023.101728_bib54","doi-asserted-by":"crossref","DOI":"10.1038\/srep46658","article-title":"Metabolism dysregulation induces a specific lipid signature of nonalcoholic steatohepatitis in patients","volume":"7","author":"Chiappini","year":"2017","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.molmet.2023.101728_bib55","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1002\/hep.21763","article-title":"A\u00a0lipidomic analysis of nonalcoholic fatty liver disease","volume":"46","author":"Puri","year":"2007","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.molmet.2023.101728_bib56","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.jhep.2013.01.006","article-title":"Essential fatty acids deficiency promotes lipogenic gene expression and hepatic steatosis through the liver X receptor","volume":"58","author":"Ducheix","year":"2013","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1016\/j.molmet.2023.101728_bib57","first-page":"1529","article-title":"Polyunsaturated fatty acids ameliorate hepatic steatosis in obese mice by SREBP-1 suppression","volume":"38","author":"Sekiya","year":"2003","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.molmet.2023.101728_bib58","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1172\/JCI25256","article-title":"Polyunsaturated fatty acids suppress glycolytic and lipogenic genes through the inhibition of ChREBP nuclear protein translocation","volume":"115","author":"Dentin","year":"2005","journal-title":"J\u00a0Clin Invest"},{"issue":"4","key":"10.1016\/j.molmet.2023.101728_bib59","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.2337\/db06-1206","article-title":"n-3 Fatty acids preserve insulin sensitivity in\u00a0vivo in a peroxisome proliferator-activated receptor-alpha-dependent manner","volume":"56","author":"Neschen","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2023.101728_bib60","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.mam.2018.03.001","article-title":"Omega-3 fatty acids and non-alcoholic fatty liver disease: evidence of efficacy and mechanism of action","volume":"64","author":"Scorletti","year":"2018","journal-title":"Mol Aspects Med"},{"issue":"5","key":"10.1016\/j.molmet.2023.101728_bib61","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.plipres.2008.03.003","article-title":"Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake","volume":"47","author":"Hodson","year":"2008","journal-title":"Prog Lipid Res"},{"issue":"1","key":"10.1016\/j.molmet.2023.101728_bib62","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/ajcn\/62.1.68","article-title":"Incorporation of dietary n-3 fatty acids into the fatty acids of human adipose tissue and plasma lipid classes","volume":"62","author":"Leaf","year":"1995","journal-title":"Am J Clin Nutr"},{"issue":"6","key":"10.1016\/j.molmet.2023.101728_bib63","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1093\/ajcn\/38.6.906","article-title":"Acyl pattern of adipose tissue triglycerides, plasma free fatty acids, and diet of a group of men participating in a primary coronary prevention program (the Oslo Study)","volume":"38","author":"Jacobsen","year":"1983","journal-title":"Am J Clin Nutr"},{"issue":"3","key":"10.1016\/j.molmet.2023.101728_bib64","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.clnu.2020.07.013","article-title":"Oxidation of dietary linoleate occurs to a greater extent than dietary palmitate in\u00a0vivo in humans","volume":"40","author":"Parry","year":"2021","journal-title":"Clin Nutr"},{"issue":"1","key":"10.1016\/j.molmet.2023.101728_bib65","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s10557-008-6132-9","article-title":"Phospholipase A2 biochemistry","volume":"23","author":"Burke","year":"2009","journal-title":"Cardiovasc Drugs Ther"},{"issue":"9","key":"10.1016\/j.molmet.2023.101728_bib66","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1194\/jlr.M060285","article-title":"The effect of phospholipid composition of reconstituted HDL on its cholesterol efflux and anti-inflammatory properties","volume":"56","author":"Schwendeman","year":"2015","journal-title":"J\u00a0Lipid Res"},{"issue":"8","key":"10.1016\/j.molmet.2023.101728_bib67","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14081570","article-title":"Effect of lipid composition on the atheroprotective properties of HDL-mimicking micelles","volume":"14","author":"Hong","year":"2022","journal-title":"Pharmaceutics"},{"issue":"5","key":"10.1016\/j.molmet.2023.101728_bib68","doi-asserted-by":"crossref","first-page":"E852","DOI":"10.1152\/ajpendo.00193.2019","article-title":"HDL flux is higher in patients with nonalcoholic fatty liver disease","volume":"317","author":"McCullough","year":"2019","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.molmet.2023.101728_bib69","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines8120625","article-title":"HDL-mediated cholesterol efflux and plasma loading capacities are altered in subjects with metabolically- but not genetically driven non-alcoholic fatty liver disease (NAFLD)","volume":"8","author":"Di Costanzo","year":"2020","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.molmet.2023.101728_bib70","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-29639-5","article-title":"Impaired HDL cholesterol efflux capacity in patients with non-alcoholic fatty liver disease is associated with subclinical atherosclerosis","volume":"8","author":"Fadaei","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.molmet.2023.101728_bib71","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/978-3-319-09665-0_2","article-title":"HDL biogenesis, remodeling, and catabolism","volume":"224","author":"Zannis","year":"2015","journal-title":"Handb Exp Pharmacol"},{"issue":"6","key":"10.1016\/j.molmet.2023.101728_bib72","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.bbagen.2009.02.010","article-title":"Hepatic uptake and metabolism of phosphatidylcholine associated with high density lipoproteins","volume":"1790","author":"Robichaud","year":"2009","journal-title":"Biochim Biophys Acta"},{"issue":"12","key":"10.1016\/j.molmet.2023.101728_bib73","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1111\/j.1365-2362.2003.01263.x","article-title":"Alterations in high-density lipoprotein metabolism and reverse cholesterol transport in insulin resistance and type 2 diabetes mellitus: role of lipolytic enzymes, lecithin:cholesterol acyltransferase and lipid transfer proteins","volume":"33","author":"Borggreve","year":"2003","journal-title":"Eur J Clin Invest"},{"issue":"8","key":"10.1016\/j.molmet.2023.101728_bib74","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1093\/cvr\/cvy077","article-title":"Identification of miR-9-5p as direct regulator of ABCA1 and HDL-driven reverse cholesterol transport in circulating CD14+ cells of patients with metabolic syndrome","volume":"114","author":"D'Amore","year":"2018","journal-title":"Cardiovasc Res"},{"issue":"8","key":"10.1016\/j.molmet.2023.101728_bib75","doi-asserted-by":"crossref","first-page":"4988","DOI":"10.1016\/j.clnu.2021.06.006","article-title":"Association of the odd-chain fatty acid content in lipid groups with type 2 diabetes risk: a targeted analysis of lipidomics data in the EPIC-Potsdam cohort","volume":"40","author":"Prada","year":"2021","journal-title":"Clin Nutr"},{"issue":"10","key":"10.1016\/j.molmet.2023.101728_bib76","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002409","article-title":"A\u00a0combination of plasma phospholipid fatty acids and its association with incidence of type 2 diabetes: the EPIC-InterAct case-cohort study","volume":"14","author":"Imamura","year":"2017","journal-title":"PLoS Med"},{"issue":"3","key":"10.1016\/j.molmet.2023.101728_bib77","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1017\/S0007114514003894","article-title":"Recommended dairy product intake modulates circulating fatty acid profile in healthy adults: a multi-centre cross-over study","volume":"113","author":"Abdullah","year":"2015","journal-title":"Br J Nutr"},{"issue":"6","key":"10.1016\/j.molmet.2023.101728_bib78","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.3945\/ajcn.117.152702","article-title":"Odd-chain fatty acids as a biomarker for dietary fiber intake: a novel pathway for endogenous production from propionate","volume":"105","author":"Weitkunat","year":"2017","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.molmet.2023.101728_bib79","doi-asserted-by":"crossref","DOI":"10.1038\/srep44845","article-title":"Odd chain fatty acids; new insights of the relationship between the gut microbiota, dietary intake, biosynthesis and glucose intolerance","volume":"7","author":"Jenkins","year":"2017","journal-title":"Sci Rep"},{"issue":"11","key":"10.1016\/j.molmet.2023.101728_bib80","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1038\/s41589-018-0132-2","article-title":"Enzyme promiscuity drives branched-chain fatty acid synthesis in adipose tissues","volume":"14","author":"Wallace","year":"2018","journal-title":"Nat Chem Biol"},{"issue":"5","key":"10.1016\/j.molmet.2023.101728_bib81","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.jhep.2016.01.002","article-title":"Hepatic ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease","volume":"64","author":"Luukkonen","year":"2016","journal-title":"J\u00a0Hepatol"},{"issue":"43","key":"10.1016\/j.molmet.2023.101728_bib82","doi-asserted-by":"crossref","first-page":"25863","DOI":"10.1074\/jbc.M115.659110","article-title":"Microsomal triglyceride transfer protein transfers and determines plasma concentrations of ceramide and sphingomyelin but not glycosylceramide","volume":"290","author":"Iqbal","year":"2015","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.molmet.2023.101728_bib83","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1146\/annurev-physiol-031620-093815","article-title":"Ceramides in metabolism: key lipotoxic players","volume":"83","author":"Chaurasia","year":"2021","journal-title":"Annu Rev Physiol"},{"issue":"8","key":"10.1016\/j.molmet.2023.101728_bib84","article-title":"Sphingolipids in HDL - potential markers for adaptation to pregnancy?","volume":"1866","author":"Patanapirunhakit","year":"2021","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"}],"container-title":["Molecular Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212877823000625?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212877823000625?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T13:22:14Z","timestamp":1778851334000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212877823000625"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":84,"alternative-id":["S2212877823000625"],"URL":"https:\/\/doi.org\/10.1016\/j.molmet.2023.101728","relation":{},"ISSN":["2212-8778"],"issn-type":[{"value":"2212-8778","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-alcoholic fatty liver disease is characterised by a reduced polyunsaturated fatty acid transport via free fatty acids and high-density lipoproteins (HDL)","name":"articletitle","label":"Article Title"},{"value":"Molecular Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmet.2023.101728","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"101728"}}